Control_NN
of_IN
NF-kappa_NN
B_NN
activity_NN
by_IN
the_DT
I_NN
kappa_NN
B_NN
beta_NN
inhibitor_NN
._.

The_DT
transcription_NN
factor_NN
NF-kappa_NN
B_NN
is_VBZ
maintained_VBN
in_IN
an_DT
inactive_JJ
cytoplasmic_JJ
state_NN
by_IN
I_NN
kappa_NN
B_NN
inhibitors_NNS
._.

In_IN
mammalian_JJ
cells_NNS
,_,
I_NN
kappa_NN
B_NN
alpha_NN
and_CC
I_CD
kappa_NN
B_NN
beta_NN
proteins_NNS
have_VBP
been_VBN
purified_VBN
and_CC
shown_VBN
to_TO
be_VB
the_DT
inhibitors_NNS
of_IN
NF-kappa_NN
B_NN
through_IN
their_PRP$
association_NN
with_IN
the_DT
p65_NN
or_CC
c-Rel_NN
subunits_NNS
._.

In_IN
addition_NN
,_,
we_PRP
have_VBP
isolated_VBN
a_DT
third_JJ
NF-kappa_NN
B_NN
inhibitor_NN
,_,
I_CD
kappa_NN
B_NN
epsilon_NN
-LRB-_-LRB-
1_CD
-RRB-_-RRB-
._.

Upon_IN
treatment_NN
with_IN
a_DT
large_JJ
variety_NN
of_IN
inducers_NNS
,_,
I_NN
kappa_NN
B_NN
alpha_NN
,_,
I_CD
kappa_NN
B_NN
beta_NN
are_VBP
proteolytically_RB
degraded_VBN
,_,
resulting_VBG
in_IN
NF-kappa_NN
B_NN
translocation_NN
into_IN
the_DT
nucleus_NN
._.

Here_RB
we_PRP
show_VBP
that_IN
in_IN
E29_NN
.1_CD
T_NN
cell_NN
hybridoma_NN
I_CD
kappa_NN
B_NN
alpha_NN
and_CC
I_NN
kappa_NN
B_NN
beta_NN
are_VBP
equally_RB
associated_VBN
with_IN
p65_NN
and_CC
that_IN
I_CD
kappa_NN
B_NN
beta_NN
is_VBZ
degraded_VBN
in_IN
response_NN
to_TO
TNF_NN
alpha_NN
in_IN
contrast_NN
to_TO
what_WP
has_VBZ
been_VBN
originally_RB
published_VBN
._.

Our_PRP$
data_NNS
also_RB
suggest_VBP
that_IN
,_,
unlike_IN
I_NN
kappa_NN
B_NN
alpha_NN
,_,
I_CD
kappa_NN
B_NN
beta_NN
is_VBZ
constitutively_RB
phosphorylated_VBN
and_CC
resynthesized_VBN
as_IN
a_DT
hypophosphorylated_VBN
form_NN
._.

The_DT
absence_NN
of_IN
slow_JJ
migrating_VBG
forms_NNS
of_IN
I_NN
kappa_NN
B_NN
beta_NN
following_VBG
stimulation_NN
suggests_VBZ
that_IN
the_DT
phosphorylation_NN
does_VBZ
not_RB
necessarily_RB
constitute_VB
the_DT
signal-induced_JJ
event_NN
which_WDT
targets_VBZ
the_DT
molecule_NN
for_IN
proteolysis_NN
._.

